Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Introduction: Patients with erectile dysfunction induced by diabetes mellitus (DMED) show a poor effect rate for oral phosphodiesterase type 5 inhibitors (PDE5is). Therefore, the new therapeutic strategy is necessary in patients with DMED. Aim: To investigate whether Tetrathiomolybdate (TM) suppleme...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yinghao Yin, MS, Jingxuan Peng, MS, Jun Zhou, MS, Hanfei Chen, MS, Dongyi Peng, PhD, Dongjie Li, PhD, Yu Gan, PhD, Guangming Yin, PhD, Yuxin Tang, PhD
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Oxford University Press 2022-02-01
Serie:	Sexual Medicine
Soggetti:	Tetrathiomolybdate Diabetes Mellitus Erectile Dysfunction Ceruloplasmin eNOS
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2050116121001355
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!